Drug breaks for HIV-infected individuals may put certain immune cells at risk

DALLAS May 2, 2002 Disruption of antiretroviral therapy by patients infected with HIV may be putting certain T-cells in their bloodstream at greater risk for infection with the deadly virus if it is allowed to rebound, a study in the May 2 issue of the journal Nature concludes.

Patients whose viral counts have fallen to nearly imperceptible levels sometimes interrupt antiviral therapy temporarily, re-starting treatment if viral levels rebound. Called structured therapy interruption, these drug breaks can increase the number of certain HIV-fighting T-cells, called CD8 T-cells, in the blood. Another type of T-cell, CD4, also plays an important role in fighting HIV.

Using data collected at UT Southwestern Medical Center at Dallas, researchers have found that, even though CD8 cells increase in number with interruption of therapy, HIV-specific CD4 cells appear to be particularly prone to infection by the virus during treatment interruption. Infections of CD4 cells hasten their destruction and help spread the disease to other cells in the body.

In time, as the patients immune system is progressively weakened, this can give rise to full-blown AIDS, researchers say.

The patient can begin taking antiviral drugs to control the virus again, although this therapy is not a cure. It is unknown how long it takes for the body to regenerate these HIV-specific CD4 cells once the bodys supply has become infected, or even if regeneration occurs with re-initiation of anti-viral treatment.

During the treatment interruption, although HIV-fighting CD8 cells increase, HIV-specific CD4 cells also become infected if the virus is allowed to rebound, said Dr. Joseph Casazza, a co-author and assistant professor of infectious disease at UT Southwestern. In effect, by taking a drug break, you could be robbing Peter to pay Paul.


Contact: Mindy Baxter
UT Southwestern Medical Center

Page: 1

Related biology news :

1. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
2. New model explains why costly insect outbreaks hard to predict
3. Spruce bark beetle outbreaks examined at Alaska Symposium
4. Ebola outbreaks are simultaneous mini-epidemics
5. Mustard-root map breaks new ground tracking gene expression
6. $51 million research facility, classroom complex breaks ground at UH
7. Some 400 fragile regions of genome more vulnerable to evolutionary breaks
8. System failure to blame for Walkerton, North Battleford outbreaks, says U of T study
9. As Vitamin B-6 levels go down, numbers of DNA strand breaks go up
10. Checkpoint protein blocks chromosome breaks at fragile sites
11. Insect infestation models may shed light on insect and disease outbreaks

Post Your Comments:

(Date:9/10/2015)... This report provides detailed descriptions of the ... emerging sensor types that will dominate in the future. ... the wearable technology hype curve in the last five ... feature with all of them is the prominence of ... useful functions. Sensors collect data about the physical and ...
(Date:9/10/2015)... Report Details The global wearable ... previous expectations of revenues, consumer adoption and even technological ... which wearables begin to achieve that mass market acceptance ... reasons is the entrance of Apple to the SmartWatches ... but the overall size of the wearable technology market. ...
(Date:9/10/2015)... Conn. , Sept. 10, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... based ecommerce site, Touch of Modern, will feature ... Wednesday, September 16 th . ... wide range of designer lifestyle products to its 7.2 ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... CORAL SPRINGS, Florida , October 13, 2015 /PRNewswire/ ... (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), ... --> ARRY ), Avanex Life Sciences Corp. (OTCQX: ... Progenix Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... universities and the biotech industry can potentially lead to ...
(Date:10/13/2015)... , Oct. 13, 2015  According to ... services will reach $102 billion by the end ... of the health industry, as it is estimated ... result of laboratory tests. In addition to diagnosing ... to evaluate disease progression, monitor drug treatment and ...
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a commercial ... with the Keck Medicine of the University of Southern California (USC) ... (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association with Pain ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
Breaking Biology Technology:
Cached News: